Investors

Welcome to the investors section of Adocia

Adocia is a biotechnology company specialized in the development of best-in-class medicines from already approved therapeutic proteins.

Adocia corporate presentation – Juin 2018 de adocia

Latest Press Releases

2018/07/25Half year report on Adocia’s liquidity agreement with Kepler Capital Markets
Read more

2018/07/18Adocia Presents First Half 2018 Financial Results
Read more

Next events

1-5 October 2018 EASD, Berlin, Germany - 54th Annual Meeting of the European Association for the Study of Diabetes
See event